SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

All news > Audio

A bitter pill to swallow: young people dislike tablets more than old

A bitter pill to swallow: young people dislike tablets more than old

Thomas Hein

Director, Sales & Business Development - Hermes

Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast.

Published: 20-Oct-2014

Kemwell CEO says environmental efforts are worth the cost

Kemwell CEO says environmental efforts are worth the cost

Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth the cost.

Published: 26-Nov-2013

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Will Downie

Senior VP Global Vusiness Development & Marketing - Catalent

Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.

Published: 23-Oct-2013

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Quincy Mattingly

Regional Manager - AlpVision

In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision.

Published: 07-May-2013

Is risk-based clinical trial monitoring too flexible for the regulators?

Is risk-based clinical trial monitoring too flexible for the regulators?

Various

Various - Various

Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA.

Published: 12-Nov-2012

Cobra Biologics talks recent fill finish acquisition and future growth plans

Cobra Biologics talks recent fill finish acquisition and future growth plans

Philip Ridley-smith

Business Development & Marketing Manager - Cobra Biologics

CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.

Published: 25-Oct-2012

Catalent says sharing with industry will not dull competetive edge

Catalent says sharing with industry will not dull competetive edge

Kurt Nielsen and Cornell Stamoran

Various - Catalent

Catalent says making its technology available to industry will not affect its competitive edge.

Published: 22-Oct-2012

Bend Research hunting new partnerships to boost bioavailability offering

Bend Research hunting new partnerships to boost bioavailability offering

David Lyon and Karen Coppens

Various - Bend Research and Dow

Bend Research is “actively” hunting new partnerships similar to its recent alliance with Dow.

Published: 17-Oct-2012

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

Andrea Schiefer

VP of European clinical operations and executive director of pharmacovigilance - Clinipace

The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July  will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer.

Published: 21-Aug-2012

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Gareth Williams

UK director of market access - Quintiles

Negotiating funding for drugs with local health authorities prior to commercialisation is the key to success for biopharmas working in the changing European market, says Quintiles.

Published: 07-Jun-2012

Home visits = regulatory thumbs up? ResearchNurses.co thinks so

Home visits = regulatory thumbs up? ResearchNurses.co thinks so

Sue Mackay

Research nursing team manager - ResearchNurses.co

The use of home visits in clinical trials could raise the chances of regulatory approval, according to ResearchNurses.co.

Published: 31-May-2012

Home visits are the key to patient retention, says ResearchNurses.co

Home visits are the key to patient retention, says ResearchNurses.co

Sue Mackay

Research nursing team manager - ResearchNurses.co

Including home visits in clinical trial designs could be the key to patient retention, according to ResearchNurses.co.

Published: 30-May-2012

R&D and commercial work together to design trials, says DIA

 R&D and commercial work together to design trials, says DIA

Zoran Antonijevic

Senior director of the centre for statistics in drug development and innovation in the US - Quintiles

‘CROs: look at the entire portfolio, not just the individual project, when planning clinical studies,’ says DIA’s adaptive design scientific working group.

Published: 22-May-2012

SGS adds formulation development services and expands US lab

SGS adds formulation development services and expands US lab

Eric Hoffman

VP Business development and marketing - North America - SGS Life Science Services

SGS has added formulation development to its service offering through the expansion of its laboratory in Illinois.

Published: 07-May-2012

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

Aiswariya Chidambaram

Market Analyst - Frost & Sullivan

The European CMO industry could be blocked by over complex layers of regulation, says Frost & Sullivan analyst Aiswariya Chidambaram.

Published: 25-Apr-2012

Improve patient compliance by designing trials around real life, says expert

Improve patient compliance by designing trials around real life, says expert

Rahlyn Gossen

Owner - Rebar Interactive

Designing trials around patients’ habits is the key to success in patient compliance, according to online recruitment specialist Rebar Interactive.

Published: 16-Apr-2012

People special: social media gets job hunters noticed

People special: social media gets job hunters noticed

Various

Various - DIA Euromeeting

Those seeking leadership positions in the pharmaceutical world should take to social networking sites to get noticed, recruitment specialists say.

Published: 10-Apr-2012

Regulatory changes: the experts give us their thoughts at DIA Euromeeting

Various

Various - DIA Euromeeting, 2012

Regulatory reform was the name of the game at this year’s DIA Euromeeting in Denmark.

Published: 05-Apr-2012

Catalent eyes emerging market expansion of end-to-end development service model

Carolyn Finkle

VP of global regulatory consulting - Catalent

Catalent wants to build on its European expansions by replicating the end-to-end drug development services model in emerging markets. 

Published: 04-Apr-2012

Comparator sourcing is a complex challenge in a globalised market says Clinigen

Comparator sourcing is a complex challenge in a globalised market says Clinigen

Peter George

CEO - Clinigen Group

Sourcing comparator drugs for trials is a complex ‘art’ that requires knowledge of trading, regional regulations and an awareness of drugmakers’ competitive concerns according to Clinigen Group CEO Peter George.

Published: 27-Mar-2012

Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing

Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing

Hedley Rees

Industry consultant - Biotech Pharmaflow

Planning supply chains early is an important part of maintaining margins but is often overlooked by Pharmas too focused on developing the next product in an era of patent expiry says industry consultant.

Published: 26-Mar-2012

European CMO market will double in just 6 years, says Frost & Sullivan

European CMO market will double in just 6 years, says Frost & Sullivan

Aiswariya Chidambaram

Healthcare market analyst - Frost & Sullivan

The European CMO sector is set to double in the next six years and will hit revenues of up to $20.75bn, according to Frost & Sullivan’s Aiswariya Chidambaram.

Published: 15-Mar-2012

Social networking is key to trial recruitment success, says expert

Social networking is key to trial recruitment success, says expert

Jamie Blackburn

Founder - Patient Nucleus

Pharma companies must become more involved in building patient communities through social media if they want to see a successful trial recruitment process according to Patient Nucleus founder Jamie Blackburn.

Published: 27-Feb-2012

An experienced CMO is key to successful biologics development says Cobra Biologics

An experienced CMO is key to successful biologics development says Cobra Biologics

Julian Hanak

Commercial director - Cobra Biologics

Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics.

Published: 25-Jan-2012

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Patricia Leuchten

CEO - The Avoca Group

Sponsor and CRO perceptions of the quality of outsourced service provision differ markedly according to a study by consulting and survey research organisation, the Avoca Group.

Published: 08-Dec-2011